{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:10:06Z","timestamp":1790226606014,"version":"4.1.0"},"reference-count":67,"publisher":"American Chemical Society (ACS)","issue":"7","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Drug-induced gene expression profiling provides a lot of useful information covering various aspects of drug discovery and development. Most importantly, this knowledge can be used to discover drugs\u2019 mechanisms of action. Recently, deep learning-based drug design methods are in the spotlight due to their ability to explore huge chemical space and design property-optimized target-specific drug molecules. Recent advances in accessibility of open-source drug-induced transcriptomic data along with the ability of deep learning algorithms to understand hidden patterns have opened opportunities for designing drug molecules based on desired gene expression signatures. In this study, we propose a deep learning model, Gex2SGen (Gene Expression 2 SMILES Generation), to generate novel drug-like molecules based on desired gene expression profiles. The model accepts desired gene expression profiles in a cell-specific manner as input and designs drug-like molecules which can elicit the required transcriptomic profile. The model was first tested against individual gene-knocked-out transcriptomic profiles, where the newly designed molecules showed high similarity with known inhibitors of the knocked-out target genes. The model was next applied on a triple negative breast cancer signature profile, where it could generate novel molecules, highly similar to known anti-breast cancer drugs. Overall, this work provides a generalized method, where the method first learned the molecular signature of a given cell due to a specific condition, and designs new small molecules with drug-like properties.<\/jats:p>","DOI":"10.1021\/acs.jcim.2c01301","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T10:46:23Z","timestamp":1679913983000},"page":"1882-1893","source":"Crossref","is-referenced-by-count":32,"title":["Gex2SGen: Designing\nDrug-like Molecules from Desired\nGene Expression Signatures"],"prefix":"10.1021","volume":"63","author":[{"given":"Dibyajyoti","family":"Das","sequence":"first","affiliation":[{"name":"TCS Research (Life Sciences Division), Tata Consultancy Services Ltd , ,","place":["Hyderabad, India, 500081"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Broto","family":"Chakrabarty","sequence":"additional","affiliation":[{"name":"TCS Research (Life Sciences Division), Tata Consultancy Services Ltd , ,","place":["Hyderabad, India, 500081"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajgopal","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"TCS Research (Life Sciences Division), Tata Consultancy Services Ltd , ,","place":["Hyderabad, India, 500081"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1961-2483","authenticated-orcid":true,"given":"Arijit","family":"Roy","sequence":"additional","affiliation":[{"name":"TCS Research (Life Sciences Division), Tata Consultancy Services Ltd , ,","place":["Hyderabad, India, 500081"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"2026081804435925100_cit1","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/clpt.2009.295","article-title":"Trends in Risks Associated\nwith New Drug Development: Success Rates for Investigational Drugs","volume":"87","author":"DiMasi","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"2026081804435925100_cit2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2020.1166","article-title":"Estimated\nResearch and Development\nInvestment Needed to Bring a New Medicine to Market, 2009-2018","volume":"323","author":"Wouters","year":"2020","journal-title":"Jama"},{"key":"2026081804435925100_cit3","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of Clinical Drug Development\nFails and How to Improve It?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin.\nB"},{"key":"2026081804435925100_cit4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1208\/s12248-012-9447-1","article-title":"Strategic Applications\nof Gene Expression:\nFrom Drug Discovery\/Development to Bedside","volume":"15","author":"Bai","year":"2013","journal-title":"AAPS J"},{"key":"2026081804435925100_cit5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrd1720","article-title":"Elucidating\nMechanisms of Drug-Induced Toxicity","volume":"4","author":"Liebler","year":"2005","journal-title":"Nat. Rev.\nDrug Discovery"},{"key":"2026081804435925100_cit6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The Gene Expression\nOmnibus Database","volume-title":"Statistical genomics","author":"Clough","year":"2016"},{"key":"2026081804435925100_cit7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line\nEncyclopedia Enables Predictive Modelling of Anticancer Drug Sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"2026081804435925100_cit8","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity\nMap: Using Gene-Expression Signatures to Connect Small Molecules,\nGenes, and Disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"2026081804435925100_cit9","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next Generation Connectivity Map: L1000 Platform and the First\n1,000,000 Profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"2026081804435925100_cit10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fonc.2020.00185","article-title":"Computational Methods\nfor the Integrative\nAnalysis of Genomics and Pharmacological Data","volume":"10","author":"Caroli","year":"2020","journal-title":"Front. Oncol."},{"key":"2026081804435925100_cit11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2105-15-79","article-title":"The Characteristic\nDirection: A Geometrical\nApproach to Identify Differentially Expressed Genes","volume":"15","author":"Clark","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"2026081804435925100_cit12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/npjsba.2016.15","article-title":"LINCS L1000\nCharacteristic Direction Signatures Search\nEngine","volume":"2","author":"Duan","year":"2016","journal-title":"NPJ Syst. Biol. Appl."},{"key":"2026081804435925100_cit13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/978-1-4939-9089-4_15","article-title":"Drug\nSignature Detection Based\non L1000 Genomic and Proteomic Big Data","volume-title":"Bioinformatics and Drug Discovery","author":"Chen","year":"2019"},{"key":"2026081804435925100_cit14","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1109\/tcbb.2021.3075299","article-title":"Network-Based Analysis of Fatal Comorbidities\nof COVID-19 and Potential Therapeutics","volume":"18","author":"Chakrabarty","year":"2021","journal-title":"IEEE\/ACM\nTrans. Comput. Biol. Bioinform."},{"key":"2026081804435925100_cit15","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1093\/bioinformatics\/btw168","article-title":"Drug-Induced Adverse Events Prediction\nwith the LINCS L1000 Data","volume":"32","author":"Wang","year":"2016","journal-title":"Bioinformatics"},{"key":"2026081804435925100_cit16","first-page":"843029","article-title":"DeepSide: A Deep\nLearning Framework for Drug Side Effect Prediction","author":"Uner","year":"2019","journal-title":"Biorxiv"},{"key":"2026081804435925100_cit17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1517\/17460441.2012.651122","article-title":"The Impact of Assay\nTechnology as Applied to Safety Assessment in\nReducing Compound Attrition in Drug Discovery","volume":"7","author":"Thomas","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"key":"2026081804435925100_cit18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13321-017-0235-x","article-title":"Molecular De-Novo Design\nthrough Deep Reinforcement Learning","volume":"9","author":"Olivecrona","year":"2017","journal-title":"J. Cheminformatics"},{"key":"2026081804435925100_cit19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1021\/acscentsci.7b00512","article-title":"Generating\nFocused\nMolecule Libraries for Drug Discovery with Recurrent Neural Networks","volume":"4","author":"Segler","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"2026081804435925100_cit20","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aap7885","article-title":"Deep Reinforcement\nLearning for de\nNovo Drug Design","volume":"4","author":"Popova","year":"2018","journal-title":"Sci. Adv."},{"key":"2026081804435925100_cit21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1021\/acs.jcim.0c01060","article-title":"Accelerating de Novo\nDrug Design against Novel Proteins Using Deep Learning","volume":"61","author":"Krishnan","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"2026081804435925100_cit22","doi-asserted-by":"publisher","first-page":"5100","DOI":"10.1021\/acs.jcim.1c01319","article-title":"De Novo Structure-Based\nDrug Design\nUsing Deep Learning","volume":"62","author":"Krishnan","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"2026081804435925100_cit23","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1021\/acs.jcim.2c00462","article-title":"An In Silico Explainable\nMultiparameter\nOptimization Approach for De Novo Drug Design against Proteins from\nthe Central Nervous System","volume":"62","author":"Bung","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"2026081804435925100_cit24","first-page":"2502","article-title":"Combinatorial Chemistry: A Review","volume":"4","author":"Rasheed","year":"2013","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"2026081804435925100_cit25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1021\/cc700187t","article-title":"Application of Combinatorial Chemistry Science on Modern\nDrug Discovery","volume":"10","author":"Kennedy","year":"2008","journal-title":"J. Comb. Chem."},{"key":"2026081804435925100_cit26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.addr.2016.05.009","article-title":"Tumor-Targeting Peptides from Combinatorial\nLibraries","volume":"110\u2013111","author":"Liu","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2026081804435925100_cit27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.coph.2009.08.004","article-title":"Novel Trends in High-Throughput\nScreening","volume":"9","author":"Mayr","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"2026081804435925100_cit28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/(sici)1098-1128(199601)16:1&lt;3::aid-med1&gt;3.0.co;2-6","article-title":"The Art and Practice\nof Structure-Based\nDrug Design: A Molecular Modeling Perspective","volume":"16","author":"Bohacek","year":"1996","journal-title":"Med. Res. Rev."},{"key":"2026081804435925100_cit29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41467-019-13807-w","article-title":"De Novo Generation of Hit-like Molecules\nfrom Gene\nExpression Signatures Using Artificial Intelligence","volume":"11","author":"Me\u0301ndez-Lucio","year":"2020","journal-title":"Nat. Commun."},{"key":"2026081804435925100_cit30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fphar.2020.00269","article-title":"Molecular Generation for Desired\nTranscriptome Changes with Adversarial Autoencoders","volume":"11","author":"Shayakhmetov","year":"2020","journal-title":"Front. Pharmacol."},{"key":"2026081804435925100_cit31","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1021\/acs.jcim.1c00967","article-title":"TRIOMPHE:\nTranscriptome-Based Inference and Generation\nof Molecules with Desired Phenotypes by Machine Learning","volume":"61","author":"Kaitoh","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"2026081804435925100_cit32","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1137\/1.9781611977172.81","article-title":"FAME: Fragment-Based Conditional\nMolecular Generation for Phenotypic Drug Discovery","volume-title":"Proceedings of the 2022 SIAM International Conference\non Data Mining (SDM)","author":"Pham","year":"2022"},{"key":"2026081804435925100_cit33","first-page":"231","article-title":"Designing Anticancer\nDrugs\nfrom Transcriptomic Data via Reinforcement Learning","volume-title":"International Conference on Research in Computational\nMolecular Biology","author":"Born","year":"2020"},{"key":"2026081804435925100_cit34","doi-asserted-by":"publisher","first-page":"bbac270","DOI":"10.1093\/bib\/bbac270","article-title":"Deep Generative\nModel for Therapeutic Targets Using\nTranscriptomic Disease-Associated Data\ue5f8USP7 Case Study","volume":"23","author":"Pereira","year":"2022","journal-title":"Brief. Bioinform."},{"key":"2026081804435925100_cit35","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL Database\nin 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2026081804435925100_cit36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1021\/ci00057a005","article-title":"SMILES, a\nChemical Language and Information System. 1. Introduction to Methodology\nand Encoding Rules","volume":"28","author":"Weininger","year":"1988","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"2026081804435925100_cit37","article-title":"Auto-Encoding\nVariational Bayes","author":"Kingma","year":"2013"},{"key":"2026081804435925100_cit38","first-page":"150","volume-title":"Rdkit: Open-Source Cheminformatics\nSoftware, 2016","author":"Landrum","year":"2016"},{"key":"2026081804435925100_cit39","volume-title":"ChemGAN Challenge for\nDrug Discovery: Can AI Reproduce Natural Chemical Diversity? ArXiv170808227\nCs Stat","author":"Benhenda","year":"2017"},{"key":"2026081804435925100_cit40","doi-asserted-by":"publisher","first-page":"W697","DOI":"10.1093\/nar\/gkac328","article-title":"SigCom LINCS: Data and Metadata Search\nEngine for a Million Gene Expression Signatures","volume":"50","author":"Evangelista","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"2026081804435925100_cit41","first-page":"1","article-title":"JeliazkovExCAPE-VDB\nAn Integrated Large Scale Dataset\nFacilitating Big Data Analysis in Chemogenomics","volume":"9","author":"Sun","year":"2017","journal-title":"J. Cheminformatics"},{"key":"2026081804435925100_cit42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-018-0914-x","article-title":"The Pro-Metastasis\nEffect of CircANKS1B in Breast Cancer","volume":"17","author":"Zeng","year":"2018","journal-title":"Mol.\nCancer"},{"key":"2026081804435925100_cit43","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank:\nA Comprehensive Resource for in Silico Drug Discovery and Exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids"},{"key":"2026081804435925100_cit44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying\nthe Chemical Beauty of Drugs","volume":"4","author":"Bickerton","year":"2012","journal-title":"Nat. Chem."},{"key":"2026081804435925100_cit45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(96)00423-1","article-title":"Experimental and\nComputational Approaches to Estimate Solubility and Permeability in\nDrug Discovery and Development Settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv.\nDrug Deliv. Rev."},{"key":"2026081804435925100_cit46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1023\/a:1019154432472","article-title":"A Proof\nof the Triangle Inequality for the Tanimoto Distance","volume":"26","author":"Lipkus","year":"1999","journal-title":"J. Math. Chem."},{"key":"2026081804435925100_cit47","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1021\/jm9602928","article-title":"The Properties of\nKnown Drugs. 1. Molecular Frameworks","volume":"39","author":"Bemis","year":"1996","journal-title":"J. Med.\nChem."},{"key":"2026081804435925100_cit48","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1021\/ci050457y","article-title":"ErG: 2D Pharmacophore\nDescriptions for Scaffold Hopping","volume":"46","author":"Stiefl","year":"2006","journal-title":"J. Chem.\nInf. Model."},{"key":"2026081804435925100_cit49","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1021\/ci980159j","article-title":"Pharmacophore Fingerprinting.\n1. Application to QSAR\nand Focused Library Design","volume":"39","author":"McGregor","year":"1999","journal-title":"J. Chem. Inf. Comput.\nSci."},{"key":"2026081804435925100_cit50","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1021\/acs.jcim.8b00234","article-title":"Fre\u0301chet ChemNet Distance:\nA Metric for Generative\nModels for Molecules in Drug Discovery","volume":"58","author":"Preuer","year":"2018","journal-title":"J. Chem.\nInf. Model."},{"key":"2026081804435925100_cit51","doi-asserted-by":"publisher","first-page":"565644","DOI":"10.3389\/fphar.2020.565644","article-title":"Molecular\nSets (MOSES):\nA Benchmarking Platform for Molecular Generation Models","volume":"11","author":"Polykovskiy","year":"2020","journal-title":"Front. Pharmacol."},{"key":"2026081804435925100_cit52","article-title":"Adam: A Method for Stochastic\nOptimization","author":"Kingma","year":"2014"},{"key":"2026081804435925100_cit53","doi-asserted-by":"publisher","first-page":"662232","DOI":"10.3389\/fphar.2021.662232","article-title":"AKT Inhibitors:\nNew\nWeapons in the Fight against Breast Cancer?","volume":"12","author":"Martorana","year":"2021","journal-title":"Front. Pharmacol."},{"key":"2026081804435925100_cit54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41419-022-04603-4","article-title":"ADRB3 Induces Mobilization and Inhibits Differentiation\nof Both Breast\nCancer Cells and Myeloid-Derived Suppressor Cells","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis"},{"key":"2026081804435925100_cit55","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5301\/ijbm.5000283","article-title":"PSMB5 Is Associated\nwith Proliferation and Drug Resistance in Triple-Negative\nBreast Cancer","volume":"33","author":"Wei","year":"2018","journal-title":"Int. J. Biol. Markers"},{"key":"2026081804435925100_cit56","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: New\nData Content and Improved Web Interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic\nAcids Res."},{"key":"2026081804435925100_cit57","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.18632\/oncotarget.13760","article-title":"Metformin\nand Propranolol Combination Prevents Cancer\nProgression and Metastasis in Different Breast Cancer Models","volume":"8","author":"Rico","year":"2017","journal-title":"Oncotarget"},{"key":"2026081804435925100_cit58","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2018.ed82","article-title":"Propranolol\nand Breast Cancer\ue5f8a Work in Progress","volume":"12","author":"Pantziarka","year":"2018","journal-title":"Ecancermedicalscience"},{"key":"2026081804435925100_cit59","doi-asserted-by":"publisher","first-page":"294","DOI":"10.12659\/msm.908139","article-title":"Proteasome Inhibitor Carbobenzoxy-l-Leucyl-l-Leucyl-l-Leucinal\n(MG132)\nEnhances Therapeutic Effect of Paclitaxel on Breast Cancer by Inhibiting\nNuclear Factor (NF)-\u039aB Signaling","volume":"24","author":"Zhang","year":"2018","journal-title":"Med.\nSci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"2026081804435925100_cit60","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3892\/or.2016.4873","article-title":"Combination Treatment with Proteasome Inhibitors and\nAntiestrogens Has a Synergistic Effect Mediated by P21WAF1 in Estrogen\nReceptor-Positive Breast Cancer","volume":"36","author":"Maynadier","year":"2016","journal-title":"Oncol. Rep."},{"key":"2026081804435925100_cit61","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.drudis.2010.12.003","article-title":"Aurora-A Kinase Inhibitor\nScaffolds and Binding Modes","volume":"16","author":"Yan","year":"2011","journal-title":"Drug Discov. Today"},{"key":"2026081804435925100_cit62","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3390\/ph14080763","article-title":"Immunotherapy Treatment\nfor Triple Negative Breast Cancer","volume":"14","author":"Berger","year":"2021","journal-title":"Pharmaceuticals"},{"key":"2026081804435925100_cit63","first-page":"106","article-title":"Current Approaches in Treatment of Triple-Negative\nBreast Cancer","volume":"12","author":"Wahba","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"2026081804435925100_cit64","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of Triple-Negative Breast Cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"2026081804435925100_cit65","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-Negative\nBreast Cancer Molecular Subtyping and Treatment Progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res"},{"key":"2026081804435925100_cit66","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/0959-8049(94)90264-x","article-title":"Amonafide\nas First-Line Chemotherapy\nfor Metastatic Breast Cancer","volume":"30","author":"Kornek","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"2026081804435925100_cit67","doi-asserted-by":"publisher","first-page":"CT050","DOI":"10.1158\/1538-7445.am2019-ct050","article-title":"Abstract\nCT050: Expansion Cohort of Phase I Study of\nOral Sapacitabine and Oral Seliciclib in Patients with Metastatic\nBreast Cancer and BRCA1\/2 Mutations","volume":"79","author":"Keenan","year":"2019","journal-title":"Cancer\nRes."}],"container-title":["Journal of Chemical Information\nand Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jcim.2c01301","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jcisd8\/article-pdf\/63\/7\/1882\/8909261\/ci2c01301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jcisd8\/article-pdf\/63\/7\/1882\/8909261\/ci2c01301.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:02:49Z","timestamp":1787043769000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jcisd8\/article\/63\/7\/1882\/850327\/Gex2SGen-Designing-Drug-like-Molecules-from"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":67,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,3,27]]},"published-print":{"date-parts":[[2023,4,10]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jcim.2c01301","relation":{},"ISSN":["1549-9596","1549-960X"],"issn-type":[{"value":"1549-9596","type":"print"},{"value":"1549-960X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]}}}